GLUCOSE

Země: Irsko

Jazyk: angličtina

Zdroj: HPRA (Health Products Regulatory Authority)

Aktivní složka:

GLUCOSE MONOHYDRATE

Dostupné s:

Baxter Healthcare Limited

ATC kód:

B05BA03

INN (Mezinárodní Name):

GLUCOSE MONOHYDRATE

Dávkování:

10 %w/v

Léková forma:

Solution for Infusion

Druh předpisu:

Product subject to prescription which may not be renewed (A)

Terapeutické oblasti:

carbohydrates

Stav Autorizace:

Marketed

Datum autorizace:

2010-06-11

Informace pro uživatele

1a
2. What you need to know before
you are given Glucose 10%
Infusion
Do NOT receive Glucose 10% Infusion if
you are suffering from any of the following
conditions
•
diabetes that is not adequately treated, allowing
your blood sugar levels to rise above normal
(uncompensated diabetes)
•
hyperosmolar coma (unconsciousness). This is a type
of coma that can occur if you have diabetes and do
not receive enough medicine.
•
thinning of the blood due to the addition of too much
fluid (haemodilution)
•
when there is too much fluid in the spaces around the
cells of the body (extracellular hyperhydration)
•
when there is a larger volume of blood in the blood
vessels than there should be (hypervolaemia)
•
a higher level of sugar in the blood than normal
(hyperglycaemia)
•
a higher level of lactate, a chemical found in the
blood, than there should be (hyperlactataemia)
•
severe kidney failure (when your kidneys do not work
well and you require dialysis)
•
uncompensated heart failure. This is heart failure
that is not adequately treated and causes symptoms
such as:
– shortness of breath
– swelling of the ankles
•
build up of fluid under the skin, affecting all parts
of the body including your brain and lungs (general
oedema)
•
liver disease that causes fluid to build up within the
abdomen (ascitic cirrhosis).
•
any condition which affects the way your body
controls your sugar level
•
to be sensitive (hypersensitivity) to glucose. This is
potential manifestations in patients with allergy to
corn.
Read all of this leaflet carefully before you are
given this medicine because it contains important
information for you.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor,
pharmacist or nurse.
•
If you get any side effects, talk to your doctor or
nurse. This includes any possible side effects not
listed in this leaflet. See section 4.
This medicine is called ‘Glucose 10% w/v Solution
for Infusion’, but will be referred to as ‘Glucose 10%
i

Charakteristika produktu

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Glucose 10% w/v Solution for Infusion
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Glucose (as monohydrate): 100.00 g/l
Each ml contains 100 mg glucose (as monohydrate).
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for infusion.
Clear solution, free from visible particles.
Osmolarity: 555 mOsm/l (approx.)
pH:
3.5 to 6.5
Calorific value: 1680 kJ/l (or 400 kcal/l) (approx.)
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Glucose 10% w/v Solution for Infusion is indicated for:
Supply of carbohydrate alone or, as required, during parenteral
nutrition.
Prevention and treatment of hypoglycaemia.
Rehydration in case of water loss and dehydration states in patients
with high carbohydrate need.
Dilution of compatible medicinal products.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
The dosage and rate of administration of Glucose 10% w/v Solution for
Infusion are determined by several factors
including the indication for use and the patient’s age, weight and
clinical condition.
_ADULTS AND ELDERLY:_
The recommended doses in Table 1 serve as a guideline for an average
adult with a body weight of approximately 70 kg.
TABLE 1.
GUIDANCE ON THE DOSE FOR ADMINISTRATION TO AN ADULT (70KG)(*)
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_7_
_/_
_0_
_4_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_2_
_1_
_9_
_1_
_8_
_8_
_4_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
*The largest